These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10868958)
1. Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. Watanabe RM; Bergman RN Diabetes; 2000 Mar; 49(3):373-82. PubMed ID: 10868958 [TBL] [Abstract][Full Text] [Related]
2. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Vølund A; Polonsky KS; Bergman RN Diabetes; 1987 Oct; 36(10):1195-202. PubMed ID: 2888696 [TBL] [Abstract][Full Text] [Related]
3. Validation of methods for measurement of insulin secretion in humans in vivo. Kjems LL; Christiansen E; Vølund A; Bergman RN; Madsbad S Diabetes; 2000 Apr; 49(4):580-8. PubMed ID: 10871195 [TBL] [Abstract][Full Text] [Related]
4. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Toffolo G; De Grandi F; Cobelli C Diabetes; 1995 Jul; 44(7):845-54. PubMed ID: 7789653 [TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion. Watanabe RM; Steil GM; Bergman RN Am J Physiol; 1998 Jan; 274(1):E172-83. PubMed ID: 9458763 [TBL] [Abstract][Full Text] [Related]
6. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599 [TBL] [Abstract][Full Text] [Related]
7. Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics. Watanabe RM; Volund A; Roy S; Bergman RN J Clin Endocrinol Metab; 1989 Oct; 69(4):790-7. PubMed ID: 2674187 [TBL] [Abstract][Full Text] [Related]
8. The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Polonsky K; Frank B; Pugh W; Addis A; Karrison T; Meier P; Tager H; Rubenstein A Diabetes; 1986 Apr; 35(4):379-86. PubMed ID: 3514322 [TBL] [Abstract][Full Text] [Related]
9. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models. Tura A; Pacini G; Kautzky-Willer A; Gastaldelli A; DeFronzo RA; Ferrannini E; Mari A Metabolism; 2012 Mar; 61(3):434-43. PubMed ID: 21944265 [TBL] [Abstract][Full Text] [Related]
10. Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Kjems LL; Vølund A; Madsbad S Diabetologia; 2001 Oct; 44(10):1339-48. PubMed ID: 11692185 [TBL] [Abstract][Full Text] [Related]
11. Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients. Christiansen E; Kjems LL; Vølund A; Tibell A; Binder C; Madsbad S Am J Physiol; 1998 Apr; 274(4):E716-25. PubMed ID: 9575834 [TBL] [Abstract][Full Text] [Related]
12. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. Nauck MA; Homberger E; Siegel EG; Allen RC; Eaton RP; Ebert R; Creutzfeldt W J Clin Endocrinol Metab; 1986 Aug; 63(2):492-8. PubMed ID: 3522621 [TBL] [Abstract][Full Text] [Related]
13. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Tura A; Ludvik B; Nolan JJ; Pacini G; Thomaseth K Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E966-74. PubMed ID: 11595652 [TBL] [Abstract][Full Text] [Related]
14. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Van Cauter E; Mestrez F; Sturis J; Polonsky KS Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497 [TBL] [Abstract][Full Text] [Related]
15. Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. Toffolo G; Breda E; Cavaghan MK; Ehrmann DA; Polonsky KS; Cobelli C Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E2-10. PubMed ID: 11120653 [TBL] [Abstract][Full Text] [Related]
16. Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. Breda E; Toffolo G; Polonsky KS; Cobelli C Diabetes; 2002 Feb; 51 Suppl 1():S227-33. PubMed ID: 11815484 [TBL] [Abstract][Full Text] [Related]
17. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094 [TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles. Alejandro R; Feldman EC; Bloom AD; Kenyon NS Diabetes; 1989 Jun; 38(6):698-703. PubMed ID: 2656339 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094 [TBL] [Abstract][Full Text] [Related]
20. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]